XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Note 5 - Notes Payable
12 Months Ended
Sep. 30, 2020
Notes to Financial Statements  
Debt Disclosure [Text Block]
NOTE 
5.
NOTES PAYABLE
 
Unrelated
 
On
August 25, 2020,
the Company borrowed
$153,000
from an unrelated party. The loan is unsecured, bears interest at a rate of
10%
and is due and payable on
August 25, 2021. 
The loan
may
not
be prepaid. After
October 29, 2019,
the Company
may
not
repay the loan without the consent of the lender. At any time after
February 21, 2021,
the full value of any unpaid principal is convertible into the Company's common stock at a variable conversion price. The conversion price is equal to: (a) if the market price is greater than or equal to
$1.10,
the greater of (
1
) the variable conversion price (defined as market price multiplied by
65
percent) and (
2
)
$0.72,
and (b) if the market price is less than
$1.10,
the lesser of (
1
) the variable conversion price and (
2
)
$0.72.
The Company incurred debt issuance costs of
$3,000
which was recorded as a debt discount.  Amortization expense related to the debt discount was
$250
during the year ended
September 30, 2020.
 
On
August 2, 2019
the Company secured a
$4,000,000
investment from an unrelated
third
party in the form of a loan. The loan was evidenced by a note which bears interest at the rate of
11%
per year, is due and payable on
August 2, 2022
and is secured by a
first
lien on Building
1
at the MCC.
 
The note holder also received a warrant which allows the holder to purchase
600,000
shares of the Company's common stock at a price of
$1.50
per share. The warrant will expire on the earlier of (i)
August 2, 2024
or (ii)
twenty
days after written notice of the holder that the daily Volume Weighted Average Price of the Company's common stock was at least
$4.00
for
twenty
consecutive trading days and the average daily volume of trades of the Company's common stock during the
twenty
trading days was at least
150,000
shares.
 
The broker for the loan received a cash commission of
$320,000
plus warrants to purchase
48,000
shares of the Company's common stock. The warrants are exercisable at a price of
$1.50
per share and expire on
August 2, 2024. 
The cash commission and the fair value of the warrants amounting to
$52,392
were recognized as a discount to the note.
 
The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the
600,000
warrants was
$562,762
which was recognized as additional paid in capital and a corresponding debt discount.
 
At
September 30, 2020,
the outstanding principal on this note was
$4,000,000
and the unamortized debt discount was
$571,483.
All debt discounts are being amortized on a straight-line basis over the terms of the note. Amortization expense related to the debt discounts was
$311,370
for the year ended
September 30, 2020.
 
December 2017
Convertible Note Offering 
 
On
December 29, 2017
the Company sold convertible notes in the principal amount of
$800,000
to a group of accredited investors. The notes bear interest at
8%
per year, are unsecured, and were due and payable on
December 31, 2018.
On
December 31, 2018,
the maturity date of the notes were extended to
December 31, 2019.
The notes were fully paid off in
January 2020.
 
The original notes included a provision to be converted at any time into shares of the Company's common stock at an initial conversion price of
$1.50
per share.
 
The note holders also received warrants which entitle the note holders to purchase up to
533,333
shares of the Company's common stock. The warrants are exercisable at a price of
$1.50
per share and expire on
October 17, 2022.
 
The placement agent for the offering received a cash commission of
$64,000,
plus warrants to purchase
106,667
shares of the Company's common stock. The warrants are exercisable at a price of
$1.50
per share and expire on
December 29, 2022.
 
The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the
640,000
warrants was
$607,024
which was recognized as additional paid in capital and a corresponding debt discount. After such allocation, the effective conversion price on the issuance date was less than the fair value of the stock into which the notes were convertible, giving rise to a beneficial conversion feature of
$128,976
which was recognized as additional paid in capital and a corresponding debt discount.
 
The
$64,000
paid to the placement agent was allocated on a pro-rata basis to the warrants and the debt which was recorded as an offset to additional paid in capital and an increase in debt discount of
$48,562
and
$15,438,
respectively.
 
During
February 2019,
a loan in the principal amount of
$30,000
was converted into
20,000
shares of common stock.
 
During
May 2018,
a loan in the principal amount of
$575,000
was converted into
383,333
shares of common stock. In addition, interest payable in the amount of
$15,233
was converted into
10,155
shares.
 
At
September 30, 2020
and
September 30, 2019,
the outstanding principal on these notes was
$0
and
$195,000,
respectively. All debt discounts are being recognized on a straight-line basis over the terms of the notes. Amortization expense related to the debt discounts were
$0
and
$51,749
for the years ended
September 30, 2020
and
2019,
respectively.
 
February 2018
Convertible Note Offering
 
On
February 12, 2018
the Company sold convertible notes in the principal amount of
$810,000
to a group of accredited investors. The notes bear interest at
8%
per year, are unsecured, and are due and payable on
December 31, 2018.
On
December 31, 2018,
the notes were extended to mature on
December 31, 2019.
At the option of the note holders, the notes
may
be converted at any time into shares of the Company's common stock at an initial conversion price of
$1.50
per share.
 
The note holders also received warrants which entitle the note holders to purchase up to
540,000
shares of the Company's common stock. The warrants are exercisable at a price of
$1.50
per share and expire on
October 17, 2022.
 
The Company allocated the proceeds between the note and the warrants based on their relative fair values. The relative fair value of the
540,000
warrants was
$523,013
which was recognized as additional paid in capital and a corresponding debt discount. After such allocation, the effective conversion price on the issuance date was less than the fair value of the stock into which the note is convertible, giving rise to a beneficial conversion feature of
$286,987
which is recognized as additional paid in capital and a corresponding debt discount.
 
During
January 2019,
a loan in the amount of
$35,000
was repaid in cash.
 
In
October 2018,
a loan in the principal amount of
$45,000
was converted into
30,000
shares of common stock. In addition, interest payable in the amount of
$1,992
was converted into
1,328
shares.
 
During
July 2018,
loans in the principal amount of
$375,000
were converted into
250,000
shares of common stock. In addition, interest payable in the amount of
$14,704
was converted into
9,802
shares.
 
In
May 2019,
loans in the principal amount of
$150,000
were converted into
100,000
shares of common stock. In addition, interest payable in the amount of
$19,521
was converted into
13,014
shares.
 
In
April 2019,
loans in the amount of
$15,000
were converted to
10,000
shares of common stock.
 
A loan in the amount of
$40,000
was repaid in
January 2020. 
On
December 31, 2019,
the remaining outstanding note in the amount of
$150,000
was extended to mature on
December 31, 2020.
 
At
September 30, 2020
and
September 30, 2019,
the outstanding principal on these notes was
$150,000
and 
$
190,000,
respectively. All debt discounts are being recognized on a straight-line basis over the terms of the notes. Amortization expense related to the debt discounts were
$0
and
$87,001
for the years ended
September 30, 2020
and
2019,
respectively.
 
Related Party
 
SCP.
On
February 1, 2016,
we entered into an agreement with an unrelated party which provided us with borrowing capacity of
$200,000.
 On
May 1, 2016,
the agreement was amended to increase the borrowing capacity to
$1,000,000.
On
July 14, 2016,
Strategic Capital Partners (“SCP”) assumed the
$521,297
loan borrowed against this credit line, increasing the total balance owed to SCP to
$2,431,646.
SCP is controlled by Benjamin J. Barton,
one
of our officers and directors and a principal shareholder. The amounts borrowed from SCP were used to fund our operations.
 
On
July 14, 2016,
we entered into a debt modification agreement whereby a portion of the debt was converted into common stock and the remaining debt was renegotiated into
two
promissory notes.
 
Of the amounts owed to SCP,
$500,000
was converted into
400,000
shares of our common stock (
$1.25
conversion rate).
 
The remaining
$1,756,646
owed to SCP was divided into
two
promissory notes.
 
The
first
note, in the principal amount of
$1,000,000,
bears interest at
9.5%
per year and matures on
December 31, 2019.
Interest is payable quarterly. The note can be converted at any time, at the option of the lender, into shares of our common stock, initially at a conversion price of
$1.25
per share.
 
The
second
note, in the principal amount of
$756,646,
bears interest at
8%
per year and matures on
December 31, 2019.
Interest is payable quarterly. The note is
not
convertible into shares of our common stock but is secured by a
first
lien on all amounts due to us by WGP. Any payments received from the sale, lease or commercialization of the property in Denver, and any amounts received from WGP, will be applied to the principal amount of the note. Otherwise, all unpaid principal and interest will be due on
December 31, 2019.
 
In connection with the debt modification agreement, we issued SCP warrants to purchase
800,000
shares of our common stock, exercisable at a price of
$1.50
per share, and warrants to purchase an additional
800,000
shares of common stock, exercisable at a price of
$3.00
per share. Both sets of warrants expired on
June 30, 2020.
We allocated the relative fair values to the warrants, stock options, and convertible debt, as determined by the Black Scholes option pricing model. Based on the Black Scholes option pricing model, a net debt premium of
$72,651
was allocated to the warrants which are reflected in additional paid-in-capital. The debt premium is being amortized on a straight-line basis over the term of the notes.
 
On
September 30, 2019,
both notes were amended and combined into
one
note, in the principal amount of
$1,756,646,
bearing interest of
9%
per year and maturing on
December 31, 2022.
Additionally, the conversion option in the
first
note was eliminated. The new note is secured by all amounts due from WGP or its affiliates. The note holders also received warrants to purchase
1,500,000
shares of the Company's common stock. The warrants are exercisable at a price of
$1.25
per share and expire on
December 31, 2022.
The debt modification was deemed substantial and was accounted for as a debt extinguishment. The fair value of the
1,500,000
warrants was
$977,110
and was recognized as loss on extinguishment of debt and the remaining unamortized premium and discount was written off during the year ended
September 30, 2019.
 
The Company made principal payments on the note of
$1,175,000
during the year ended
September 30, 2020.
Accrued interest on the note was
$26,246
and
$12,283
at
September 30, 2020
and
September 30, 2019,
respectively.
 
At
September 30, 2020,
the outstanding principal on this note was
$581,646,
and the unamortized debt premium was
$0.
Amortization of debt premium was
$0
and
$25,673
for the years ended
September 30, 2020
and
2019,
respectively.
 
During the year ended
September 30, 2020,
the Company also incurred
$180,000
of consulting expenses with SCP of which
$65,000
remains outstanding at
September 30, 2020.